Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programmes across six African countries.
ART initiation
Africa
early infant diagnosis
point of care
turnaround times
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
revised:
15
01
2021
received:
17
09
2020
accepted:
27
01
2021
entrez:
21
3
2021
pubmed:
22
3
2021
medline:
18
9
2021
Statut:
ppublish
Résumé
Point-of-care (POC) early infant diagnosis (EID) testing has been shown to dramatically decrease turnaround times from sample collection to caregiver result receipt and time to ART initiation for HIV-positive infants compared to centralized laboratory testing. As governments in sub-Saharan Africa implement POC EID technologies, we report on the feasibility and effectiveness of POC EID testing and the impact of same-day result delivery on rapid ART initiation within national programmes across six countries. This pre-/post-evaluation compared centralized laboratory-based (pre) with POC (post) EID testing in 52 facilities across Cameroon, Democratic Republic of Congo, Ethiopia, Kenya, Senegal and Zimbabwe between April 2017 and October 2019 (country-dependent). Data were collected retrospectively from routine records at health facilities for all infants tested under two years of age. Hazard ratios and 95% confidence intervals were calculated to compare time-to-event outcomes, visualized with Kaplan-Meier curves, and the Somers' D test was used to compare continuous outcomes. Data were collected for 2892 EID tests conducted on centralized laboratory-based platforms and 4610 EID tests on POC devices with 127 (4%) and 192 (4%) HIV-positive infants identified, respectively. POC EID significantly reduced the time from sample collection to caregiver result receipt (POC median: 0 days, IQR: 0 to 0 vs. centralized: 35 days, IQR: 26 to 56) and time from sample collection to ART initiation for HIV-positive infants (POC median: 1 day, IQR: 0 to 7 vs. centralized: 39 days, IQR: 26 to 57). With POC testing, 72% of infants received results on the same day as sample collection; HIV-positive infants with a same-day diagnosis had six times the rate of ART initiation compared to those diagnosed one or more days after sample collection (HR: 6.39; 95% CI: 3.44 to 11.85). Same-day diagnosis and treatment initiation for infants is possible with POC EID within routine government-led and -supported public sector healthcare facilities in resource-limited settings. Given that POC EID allows for rapid ART initiation, aligning to the World Health Organization's recommendation of ART initiation within seven days, its use in public sector programmes has the potential to reduce overall mortality for infants with HIV through early treatment initiation.
Identifiants
pubmed: 33745234
doi: 10.1002/jia2.25677
pmc: PMC7981587
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25677Informations de copyright
© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
PLoS One. 2020 Oct 9;15(10):e0240621
pubmed: 33035274
Lancet HIV. 2016 Nov;3(11):e539-e548
pubmed: 27658873
J Acquir Immune Defic Syndr. 2020 Jul 1;84 Suppl 1:S41-S48
pubmed: 32520914
AIDS. 2018 Jul 17;32(11):1453-1463
pubmed: 29746301
PLoS Med. 2011 Jul;8(7):e1001056
pubmed: 21811403
PLoS One. 2018 Mar 2;13(3):e0193577
pubmed: 29499042
PLoS Med. 2016 May 10;13(5):e1002015
pubmed: 27163694
Stat Methods Med Res. 2020 Nov;29(11):3424-3454
pubmed: 32466712
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):e1-4
pubmed: 24933096
J Acquir Immune Defic Syndr. 2020 Jul 1;84 Suppl 1:S12-S21
pubmed: 32520910
J Acquir Immune Defic Syndr. 2020 Jul 1;84 Suppl 1:S5-S11
pubmed: 32520909
Clin Infect Dis. 2018 Aug 16;67(5):701-707
pubmed: 29490026
AIDS. 2021 Feb 2;35(2):287-297
pubmed: 33394672
Lancet HIV. 2019 Mar;6(3):e182-e190
pubmed: 30737187
PLoS One. 2019 Jun 27;14(6):e0218369
pubmed: 31246963
J Acquir Immune Defic Syndr. 2020 Jul 1;84 Suppl 1:S70-S77
pubmed: 32520918
Lancet HIV. 2019 Jun;6(6):e373-e381
pubmed: 30987937